Gland Pharma News

Fosun Pharma divested a 6% stake in Gland Pharma for ₹2,800 crore through a block deal, reducing its holding to 45.77%. Major buyers included Kotak, Axis, and I

Fosun Pharma is expected to divest a 5% equity stake in Gland Pharma, valued at Rs 2,279 crore, through a block deal. This comes after Gland Pharma reported a 4

Piper Serica founder Abhay Agarwal announced that the firm has exited its shares in CDSL and CAMS, and has instead added Gland Pharma and Astra Microwave to its

Gland Pharma has appointed Deepak Sapra, a senior executive from Dr Reddy's Laboratories with 27 years of experience, as its new Chief Executive Officer. His te

Gland Pharma shares surged 12% after reporting a 47% year-on-year profit increase and 20% revenue growth in Q1FY27. Despite strong performance, Elara Securities

Gland Pharma reported a 47% surge in its Q1 net profit to ₹317 crore, driven by higher revenue from recent product launches in its CDMO portfolio and strong cus

Gland Pharma has secured a strategic Manufacturing and Supply Agreement with a major global pharmaceutical company for sterile injectable products, covering 55

Gland Pharma is set to establish a sterile manufacturing suite for Neuland Labs to meet the increasing global demand for sterile Active Pharmaceutical Ingredien

Gland Pharma has received USFDA approval for its generic version of sugammadex injection, a drug used to reverse muscle relaxant effects during surgery. The app